|
IR News |
|
IR Calendar |
-
2025/11/06
Second Quarter Results for FY2025 available
-
2025/11/06
Notice Concerning Determination of Matters Related to Repurchase of Own Shares
（118KB）
-
2025/11/05
Notice Concerning Progress on Repurchase of Own Shares
（106KB）
-
2025/10/31
Ajinomoto Co., Inc. Enters Licensing Agreement with Astellas Pharma Inc. for Biopharmaceutical Development and Manufacturing Technology
（348KB）
-
2025/10/24
Supporting the Health and Lives of People Around the World
Amino Acids for Pharmaceuticals and Foods
（424KB）
November 6, 2025 6:00 p.m.
- Analysts' Meeting for the second quarter ended September 30, 2025
November 6, 2025 3:30 p.m.
- Announcement of financial results for the second quarter ended September 30, 2025
October 14, 2025 9:00 a.m.
- Business Briefing
August 4, 2025 5:00 p.m.
- Conference call for the first quarter ended June 30, 2025
August 4, 2025 3:30 p.m.
- Announcement of financial results for the first quarter ended June 30, 2025
June 26, 2025 9:00 a.m.
- Business Briefing
May 8, 2025 6:00 p.m.
- Analysts' Meeting for the fiscal year ended March 31, 2025
May 8, 2025 3:30 p.m.
- Announcement of financial results for the fiscal year ended March 31, 2025
April 4, 2025 10:00 a.m.
- IR Day
February 3, 2025 5:30 p.m.
- Analysts' Meeting for the third quarter ended December 31, 2024
February 3, 2025 3:30 p.m.
- Announcement of financial results for the third quarter ended December 31, 2024
November 7, 2024 6:00 p.m.
- Analysts' Meeting for the second quarter ended September 30, 2024
November 7, 2024 3:30 p.m.
- Announcement of financial results for the second quarter ended September 30, 2024
Company Profile available in following Languages. (EUROLAND)
We give you a quick insight into who we are and what we do.
